{"id":"F2019L00634","name":"Statement of Principles concerning rapidly progressive crescentic glomerulonephritis (Balance of Probabilities) (No. 46 of 2019)","slug":"statement-of-principles-concerning-rapidly-progressive-crescentic-glomerulonephritis-balance-of-prob","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":440046,"registerId":"F2019L00634-fast-fetch-1775955832761","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning rapidly progressive crescentic glomerulonephritis (Balance of Probabilities) (No. 46 of 2019)","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n\n\n \n\nStatement of Principles\n\nconcerning\n\nRAPIDLY PROGRESSIVE CRESCENTIC GLOMERULONEPHRITIS (Balance of Probabilities)\n\n(No. 46 of 2019)\n\nThe Repatriation Medical Authority determines the following Statement of Principles under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n \n\nDated 26 April 2019\n\n \n\n \n\n \n\n \n\n \n\n| The Common Seal of the Repatriation Medical Authority was affixed to this instrument at the direction of:
|\n| --- |\n| 
Professor Nicholas Saunders AO
Chairperson
|\n\n\n \n\n \n\n\nContents\n\n1 Name\n\n2 Commencement\n\n3 Authority\n\n4 Repeal\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\n \n\n\n\n\n1 Name\n\nThis is the Statement of Principles concerning rapidly progressive crescentic glomerulonephritis (Balance of Probabilities) (No. 46 of 2019).\n\n2 Commencement\n\n This instrument commences on 27 May 2019.\n\n3 Authority\n\nThis instrument is made under subsection 196B(3) of the Veterans' Entitlements Act 1986.\n\n4 Repeal\n\nThe Statement of Principles concerning rapidly progressive crescentic glomerulonephritis No. 82 of 2010 (Federal Register of Legislation No. F2010L02338) made under subsection 196B(3) of the VEA is repealed.\n\n5 Application\n\nThis instrument applies to a claim to which section 120B of the VEA or section 339 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about rapidly progressive crescentic glomerulonephritis and death from rapidly progressive crescentic glomerulonephritis.\n\nMeaning of rapidly progressive crescentic glomerulonephritis\n\n(2) For the purposes of this Statement of Principles, rapidly progressive crescentic glomerulonephritis means a form of glomerulonephritis where there are extensive cellular crescents on histopathology and a rapid decline in renal function over a period of weeks to months.\n\nDeath from rapidly progressive crescentic glomerulonephritis\n\n(3) For the purposes of this Statement of Principles, rapidly progressive crescentic glomerulonephritis, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's rapidly progressive crescentic glomerulonephritis.\n\nNote: terminal event is defined in the Schedule 1 – Dictionary.\n\n8 Basis for determining the factors\n\nOn the sound medical‑scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that rapidly progressive crescentic glomerulonephritis and death from rapidly progressive crescentic glomerulonephritis can be related to relevant service rendered by veterans or members of the Forces under the VEA, or members under the MRCA.\n\nNote: MRCA, relevant service and VEA are defined in the Schedule 1 – Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must exist before it can be said that, on the balance of probabilities, rapidly progressive crescentic glomerulonephritis or death from rapidly progressive crescentic glomerulonephritis is connected with the circumstances of a person's relevant service:\n\n(1) having an infection from the specified list of infections within the two months before the clinical onset of rapidly progressive crescentic glomerulonephritis;\n\nNote: specified list of infections is defined in the Schedule 1 - Dictionary. \n\n(2) having an autoimmune disorder from the specified list of autoimmune disorders at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;\n\nNote: specified list of autoimmune disorders is defined in the Schedule 1 - Dictionary. \n\n(3) having infiltration of the kidneys due to a disorder from the specified list of infiltrative disorders at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;\n\nNote: specified list of infiltrative disorders is defined in the Schedule 1 - Dictionary. \n\n(4) having a renal disorder from the specified list of renal disorders at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;\n\nNote: specified list of renal disorders is defined in the Schedule 1 - Dictionary. \n\n(5) having a malignant neoplasm at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;\n\n(6) taking a drug from the specified list of drugs within the seven days before the clinical onset of rapidly progressive crescentic glomerulonephritis;\n\nNote: specified list of drugs is defined in the Schedule 1 - Dictionary.\n\n(7) inability to obtain appropriate clinical management for rapidly progressive crescentic glomerulonephritis.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factor set out in subsection 9(7) applies only to material contribution to, or aggravation of, rapidly progressive crescentic glomerulonephritis where the person's rapidly progressive crescentic glomerulonephritis was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(3) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\n \n\n \n\nSchedule 1 - Dictionary \n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\n MRCA means the Military Rehabilitation and Compensation Act 2004.\n\n rapidly progressive crescentic glomerulonephritis—see subsection 7(2).\n\n relevant service means:\n\n(a) eligible war service (other than operational service) under the VEA;\n\n(b) defence service (other than hazardous service and British nuclear test defence service) under the VEA; or\n\n(c) peacetime service under the MRCA.\n\nNote: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\n specified list of autoimmune disorders means:\n\n(a) anti-glomerular basement membrane disease (Goodpasture disease);\n\n(b) antiphospholipid syndrome;\n\n(c) Behcet disease;\n\n(d) cryoglobulinaemia;\n\n(e) eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome);\n\n(f) granulomatosis with polyangiitis (Wegener granulomatosis);\n\n(g) Henoch-Schonlein purpura;\n\n(h) inflammatory bowel disease;\n\n(i) microscopic polyangiitis;\n\n(j) mixed connective tissue disease;\n\n(k) relapsing polychondritis;\n\n(l) rheumatoid arthritis;\n\n(m) Sjogren syndrome;\n\n(n) systemic lupus erythematosus; or\n\n(o) systemic sclerosis.\n\n specified list of drugs means:\n\n(a) benzylthiouracil;\n\n(b) carbimazole;\n\n(c) cocaine adulterated with levamisole;\n\n(d) D-penicillamine;\n\n(e) hydralazine;\n\n(f) levamisole;\n\n(g) propylthiouracil; or\n\n(h) rifampicin.\n\n specified list of infections means:\n\n(a) bacterial infection;\n\n(b) hepatitis B;\n\n(c) hepatitis C;\n\n(d) human immunodeficiency virus infection; or\n\n(e) infective endocarditis.\n\n specified list of infiltrative disorders means:\n\n(a) amyloidosis;\n\n(b) light-chain deposition disease; or\n\n(c) sarcoidosis.\n\n specified list of renal disorders means:\n\n(a) fibrillary glomerulonephritis;\n\n(b) immunoglobulin A nephropathy (including mesangial IgA glomerulonephritis);\n\n(c) immunoglobulin G4-related kidney disease (including tubulointerstitial nephritis and membranous glomerulonephritis secondary to immunoglobulin G4-related disease);\n\n(d) membranoproliferative glomerulonephritis; or\n\n(e) membranous glomerulonephritis.\n\n terminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\n VEA means the Veterans' Entitlements Act 1986.\n\n \n\n \n","sortOrder":0}],"analysis":{"flash_summary":{"complexity_score":4,"scope_assessment":{"changed":false,"description":"The instrument expressly repeals the 2010 Statement (s4) and reissues criteria (s5). It applies to the same classes of claims under the VEA and MRCA (s5) and sets the balance‑of‑probabilities medical test (s8) with specified factor lists (s9, Schedule 1). The text does not indicate an explicit expansion or narrowing of eligible claim types compared with the prior instrument; any substantive scope change is not stated in this instrument."},"complexity_factors":["Multiple medically technical specified lists in Schedule 1 (autoimmune disorders, infections, drugs, infiltrative and renal disorders) increase evidentiary complexity (Schedule 1).","Legal causation standard is balance of probabilities but coupled with medical-scientific assessment, requiring expert evidence (s8, s9).","Temporal rules and exposure windows (e.g. infections within 2 months, drugs within 7 days) create tight temporal causation requirements (s9(1), s9(6)).","Conditional provision for inability to obtain appropriate clinical management applies only where condition pre‑dated service and is limited to material contribution or aggravation, creating a narrow exception (s9(7), s10(2)).","Requirement that any qualifying factor be related to the person’s relevant service adds an additional legal link to be proved (s10(1)).","Interaction with other Statements of Principles means medical conditions covered elsewhere must be assessed under those instruments, adding administrative layering (s11).","Definitions and inclusion of death via terminal events broaden application but require linking proximate causes (s7(3), Schedule 1 terminal event).","Administrative changes (repeal of prior statement; commencement date) require attention to applicable instrument for claims spanning the transition (s2, s4, s5)."],"plain_english_summary":"Mechanically, this Statement replaces a prior instrument and sets the legal medical criteria for linking rapidly progressive crescentic glomerulonephritis (and death from it) to a veteran’s or service member’s relevant service for claims under the VEA or MRCA. It requires, on the balance of probabilities, at least one specified factor (for example recent infections, listed autoimmune or renal disorders, certain drugs, malignancy, or inability to obtain appropriate care) that is related to the person’s relevant service before a claim can succeed."},"kimi_summary":{"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"This is a standard replacement Statement of Principles under the Veterans' Entitlements Act 1986. It maintains the same scope as its 2010 predecessor and other similar instruments—establishing medical causation factors for a specific disease in veterans' compensation claims. The structure and approach are consistent with the original legislative intent of subsection 196B(3) of the VEA."},"complexity_factors":["Multiple defined lists in Schedule 1 (5 separate 'specified lists' containing 8 drugs, 15 autoimmune disorders, 5 infections, 3 infiltrative disorders, and 5 renal disorders)","Cross-referencing between the main instrument and Schedule 1 dictionary","Temporal conditions requiring precise timing ('within two months before', 'within seven days before', 'at the time of')","Nested conditional logic in section 10(2) restricting the 'inability to obtain appropriate clinical management' factor to pre-existing conditions","Section 11 creates dynamic incorporation of other Statements of Principles by reference ('as in force from time to time')","Dual statutory framework application (VEA and MRCA with different service definitions)"],"plain_english_summary":"This instrument sets the rules for when Australian veterans and Defence Force members can claim compensation for rapidly progressive crescentic glomerulonephritis (RPCG), replacing the 2010 version and applying to claims under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004.\n\nIt identifies categories of service‑connected medical factors (e.g., specific infections, autoimmune or kidney disorders, certain drugs, cancer, or lack of timely treatment) that, on the balance of probabilities, support a successful claim—ensuring consistent DVA decision‑making."},"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-rapidly-progressive-crescentic-glomerulonephritis-balance-of-prob","history":"/api/acts/statement-of-principles-concerning-rapidly-progressive-crescentic-glomerulonephritis-balance-of-prob/history","analysis":"/api/acts/statement-of-principles-concerning-rapidly-progressive-crescentic-glomerulonephritis-balance-of-prob/analysis","conflicts":"/api/acts/statement-of-principles-concerning-rapidly-progressive-crescentic-glomerulonephritis-balance-of-prob/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-rapidly-progressive-crescentic-glomerulonephritis-balance-of-prob/important-cases","documents":"/api/acts/statement-of-principles-concerning-rapidly-progressive-crescentic-glomerulonephritis-balance-of-prob/documents"}}